Back to search

Netherlands· NL-c2060c28cefd

Dopacis 90 MBq/ml, oplossing voor injectie

A fluorodopa (18f) product containing fluorodopa [18f], registered in Netherlands by Cis Bio International. The same ATC class is registered in 6 of our 19 countries.

ATC V09IX05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDopacis 90 MBq/ml, oplossing voor inj…ATCV09IX05REGISTER NO.NL-c2060c28cefdPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Fluorodopa (18f) is registered in 6 of 19 countries.

Countries holding a registration under ATC V09IX05 (fluorodopa (18f)), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose

Fluorodopa (18f) · ATC V09IX05

6 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Germany
  • Netherlands
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FLUORODOPA [18F]
Manufacturer
Cis Bio International
Country
Netherlands (NL)
ATC code
V09IX05
ATC class
Fluorodopa (18F)
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    107820

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluorodopa (18f) in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluorodopa (18f) products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Iasodopa
  • Belgium · Fluorodopa (18f) Cis Bio International
  • Czechia · Fluorodopa (18f) Ujv
  • Germany · Doparos, Dopaview
  • Spain · Dopacis, Dopaview
  • France · Dopacis, Dopaview
  • Hungary · Fdopa Kedoi
  • Italy · Fluorodopa (18f) Curium Italy, Fluorodopa Iason
  • Luxembourg · Dopacis
  • Malta · Dopacis
  • Portugal · Dopacis, Dopaview
  • Slovenia · Dopacis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3b4704bc-e088-430d-b37f-bffb807ebd4d
GET /v1/drugs/3b4704bc-e088-430d-b37f-bffb807ebd4d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h107820_smpc.pdf",
  "strength": null,
  "atc_label": "Fluorodopa (18F)",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg107820",
  "excipients": [
    "ASCORBINEZUUR (E 300)",
    "AZIJNZUUR (E 260)",
    "DINATRIUMEDETAAT 0-WATER",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "FLUORODOPA [18F]"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h107820.pdf",
  "authorised_at": "2011/01/17",
  "procedure_number": "FR/H/0440/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "107820",
  "additional_monitoring": "N"
}

See everything about fluorodopa (18f).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.